Episode 42: Darnisha Harrison - Using Therapeutics to Tackle COVID-19

LSU Experimental

Inhoud geleverd door LSU Experimental, LSU Communication across the Curriculum, and LSU College of Science. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door LSU Experimental, LSU Communication across the Curriculum, and LSU College of Science of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.

3+ y ago 41:51

MP3•Thuis aflevering

COVID-19 has upended our lives in how we interact and function. As of September 2021, the Centers for Disease Control estimate over 40 million people have been sick and approximately 652,000 people have died in the United States. We see that vaccines and mask-wearing are effective in controlling the spread, but people are still getting sick. We can’t fully eradicate COVID, but what if we could more effectively treat the symptoms of those infected and shorten the duration of their illness? LSU alumna, Darnisha Harrison, the Founder, President & CEO of Ennaid Therapeutics is working to answer that question. In this episode, Darnisha shares the inception of her company and the driving, divine mission to tackle diseases and identify treatments suitable for all of society. Catch more of Darnisha Harrison's story on a previous post on Science Next, "Will it take more than a vaccine to beat the Coronavirus?" Learn about Ennaid Therapeutics: https://ennaidthera.com/

5 afleveringen

#LSU Experimental #LSU College of Science #LSU Communication across the Curriculum #Podcasting Education